Hyloris Pharmaceuticals SA (EBR:HYL)

Belgium · Delayed Price · Currency is EUR

4.400

-0.020 (-0.45%)

Aug 31, 2026, 3:07 PM CET

Hyloris Pharmaceuticals Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	7.94	7.94	9.76	3.76	2.39	3.1
Revenue Growth	-6.15%	-18.66%	159.64%	57.48%	-22.90%	1669.14%
Gross Profit	7.56	7.56	9.53	3.67	2.29	2.99
Operating Income	-8.15	-8.15	-6.37	-15.85	-11.51	-10.33
Net Income	-6.33	-6.33	-6.34	-15.38	-11.91	-11.58
Earnings Per Share	-0.23	-0.23	-0.23	-0.55	-0.44	-0.45
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	4.7	4.7	5.59	1.13
EMEA and Asia-Pacific	2.51	2.51	2.87	-
Total	7.21	7.21	8.46	1.13

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	13.78	13.78	23.59	30.41	43.93	50.54
Total Debt	1.61	1.61	1.82	1.75	0.89	8.79
Net Cash (Debt)	12.17	12.17	21.78	28.66	43.04	41.75
Net Cash Growth	-30.37%	-44.14%	-24.00%	-33.42%	3.09%	-25.39%
Net Cash Per Share	0.43	0.43	0.78	1.02	1.58	1.62

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-6.99	-6.99	-7.19	-12.81	-13.02	-11.25
Capital Expenditures	-0	-0	-0.03	-0.3	-0.1	-0.11
Free Cash Flow	-6.99	-6.99	-7.22	-13.11	-13.12	-11.36
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	95.23%	95.23%	97.67%	97.53%	96.06%	96.54%
Operating Margin	-102.61%	-102.61%	-65.26%	-421.55%	-482.11%	-333.50%
Pretax Margin	-84.49%	-84.49%	-64.98%	-409.15%	-498.62%	-364.41%
Profit Margin	-79.78%	-79.78%	-64.98%	-409.15%	-498.78%	-374.00%
FCF Margin	-88.08%	-88.08%	-74.00%	-348.66%	-549.69%	-366.83%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	15.59	24.12	18.76	94.97	130.24	144.35